Recombinant high-density lipoproteins and their use in cardiovascular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant high-density lipoproteins and their use in cardiovascular diseases

Published:2017-01 Issue:1 Volume:22 Page:180-185
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Cao Yi-ni,Xu Lu,Han Ying-chun,Wang Yu-nan,Liu George,Qi Rong

Funder

National Natural Science Foundation

National Basic Research Program of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference57 articles.

1. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study;Castelli;JAMA,1986

2. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial;Boden;Am. J. Cardiol.,2000

3. High-density lipoprotein function, dysfunction, and reverse cholesterol transport;Fisher;Arterioscler. Thromb. Vasc. Biol.,2012

4. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins;Brewer;Biochem. Biophys. Res. Commun.,1978

5. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I;Anantharamaiah;Arteriosclerosis,1990

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy;Journal of Drug Targeting;2024-05-03

2. Protective and Regenerative Effects of Reconstituted HDL on Human Rotator Cuff Fibroblasts under Hypoxia: An In Vitro Study;Antioxidants;2024-04-22

3. Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy;Acta Biomaterialia;2022-10

4. Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids;Molecular Pharmaceutics;2022-09-16

5. An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis;Small;2022-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3